Side effects at Wegovy's highest doses — what the evidence actually shows

The moment the new dose lands in your system

Picture the situation: your prescriber has moved you to 2.4mg, or you are partway through the extended titration towards the newer 7.2mg dose. The first few days feel different. Nausea arrives earlier in the day than it did on lower doses. Food you normally enjoy seems less appealing. Some people notice loose stools or constipation, occasionally both, at different points in the week. Burping, reflux, and a vague sense of fullness that lingers longer than expected are all common. These are the gastrointestinal effects that semaglutide is known for, and they are described in detail on the Wegovy 2.4mg side-effects page.

The NHS medicines information for semaglutide confirms that nausea, vomiting, diarrhoea, constipation, stomach pain, and indigestion are the most frequently reported effects across the dose range. At the highest doses, the frequency is higher, the OASIS 4 trial reported GI side effects in around 74% of participants on semaglutide versus 42% on placebo. That figure sounds large; in practice, most of those events were mild to moderate and settled within a fortnight of each dose step. Eating smaller portions, staying well hydrated, and avoiding rich or fatty meals during the adjustment window helps considerably.

Fatigue and headache also appear more often after a dose increase. Neither is dangerous, but both are worth tracking. If you keep a brief note of when symptoms appear relative to your injection day, the pattern usually becomes obvious, and that information is genuinely useful when your prescriber reviews your next dose decision. Our prescribers discuss exactly these patterns as part of every consultation; if you have questions about suitability or want to explore starting treatment, you can begin a free consultation here.

Side effects unique to the 7.2mg dose, what is known so far

Wegovy 7.2mg is newer. The MHRA approved the dedicated single-dose 7.2mg pen in April 2026, making it the highest licensed dose of semaglutide available in the UK. Trial data reported an average weight loss of around 20.7% over 72 weeks at this dose (appreciably higher than the 2.4mg results) but the trade-off is a steeper GI burden for some people.

The side-effect profile at 7.2mg follows the same categories as lower doses: nausea, vomiting, diarrhoea, and constipation lead the list. What changes is intensity and, for a minority of patients, duration. Those who found 2.4mg manageable sometimes need a longer settling period at 7.2mg before the effects plateau. Injection-site reactions (mild redness, bruising, or itching) are also reported at roughly similar rates across the dose range and are rarely a reason to stop treatment. The full Wegovy dose guide covers how the titration schedule works from the 0.25mg starting point upwards.

Because 7.2mg data is more recent and the population exposed is smaller than for 2.4mg, some rarer effects are still being characterised through post-marketing surveillance. If you want a thorough breakdown of what the trial data and emerging real-world reports show, our page on high dose Wegovy side effects brings together everything currently known. The Black Triangle (▼) on Wegovy's licence signals that additional MHRA monitoring continues; this is standard for newer medicines and not a mark of unusual danger. Reporting your own experience through the Yellow Card scheme actively contributes to that safety picture.

When higher-dose side effects need urgent medical attention

Most of what you experience at the top of the Wegovy dose range is uncomfortable rather than dangerous. A handful of symptoms, though, call for same-day medical help, not a wait-and-see approach.

Acute pancreatitis is the most important one to know. In January 2026, the MHRA's Drug Safety Update for GLP-1 medicines specifically highlighted it as an infrequent but serious risk. The symptom to act on is severe, persistent stomach pain that radiates to your back, with or without vomiting. If that happens, stop the injection and seek urgent care the same day. Gallbladder problems (sudden pain in the upper right abdomen, especially after eating) are in the same category. Both are uncommon, but neither should be managed at home.

Severe dehydration from prolonged vomiting or diarrhoea can affect kidney function. Signs include very dark urine, dizziness on standing, and significantly reduced output. Drink fluids steadily; if you cannot keep water down for more than a few hours, contact your GP or 111. Allergic reactions (rash, swelling of the face or throat, difficulty breathing) are rare but constitute an emergency. Any sudden change in vision warrants prompt assessment. Our clinical team profile at our clinical team page explains the prescribing oversight behind every treatment decision at nume. Broader information on what to watch for across all weight-loss medicines is on our weight management overview.

Managing higher-dose side effects safely, practical points

The practical steps that help at 2.4mg are broadly the same at 7.2mg, just more important to follow consistently. Smaller meals, eaten slowly, spread across the day. Protein at each meal helps preserve muscle while appetite is suppressed. Plain water rather than fizzy drinks. Avoiding fatty or heavily spiced food in the first week or two after each dose step. Many people find nausea is worse in the morning; some find eating a small amount before the injection-day evening helps.

Injection technique matters more than people expect. Rotating sites (abdomen, thigh, upper arm) reduces local reactions. The pen is stored in the fridge between 2–8°C; the exact window for keeping it at room temperature before use is set out in the Patient Information Leaflet, and that is the source to follow rather than estimates online. At nume, your pen arrives by tracked DPD delivery in plain, unbranded packaging, that plain box is something patients tell us they notice and appreciate.

If you are already using Wegovy and struggling at a higher dose, a conversation with your prescriber (not an online forum) is the right next step. Dose pauses or reverting to the previous step for another month are legitimate clinical options, and our guide to Wegovy higher dose side effects covers those conversations in more detail. People who have recently moved up from the starting point may also find it helpful to read about what to expect from Wegovy 1mg side effects, since understanding how your body responded earlier in the titration can put the current adjustment in useful context. The NHS semaglutide medicines page sets out the full list of known effects as reported in the SmPC. Our frequently asked questions page covers common concerns about starting and adjusting treatment, and you can always reach the team through our contact page if something specific is worrying you.